Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN102180886B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102180886B details a novel enantioselective route to Galanthamine using organocatalysis, offering high purity and scalable manufacturing for pharmaceutical supply chains.